Accrol Group Holdings PLC New manufacturing facility (7580I)
September 02 2016 - 2:00AM
UK Regulatory
TIDMACRL
RNS Number : 7580I
Accrol Group Holdings PLC
02 September 2016
2(nd) September 2016
Accrol Group Holdings plc (the "Company" or "Accrol")
New manufacturing facility in Leyland, Lancashire to support the
Company's growth plans
Accrol Group Holdings plc, the AIM listed leading independent
tissue converter, is pleased to announce that it has reached an
agreement with Lancashire County Developments (Property) Ltd (the
economic development arm of Lancashire County Council) to lease a
new 168,000 sq. ft. facility in Leyland, Lancashire. The new
facility will support the Company's continued growth with both the
Discounters and the Major Multiples in the UK.
The new property will initially house two high speed tissue
converting lines purchased by Accrol in April 2016 and also provide
finished goods warehousing space, with potential to add two further
converting lines if required.
Installation and commissioning of the first two lines will take
place during late 2016, with manufacturing planned to start in
January 2017. The project is expected to create around 80 new
jobs.
Commenting on the new facilities, Steve Crossley, Accrol's CEO
said:
"This additional capacity underlines our strategy of investment
ahead of growth in state-of-the-art machinery and facilities. It
will position Accrol to benefit from underlying organic growth in
the Discount sector and enable further growth with the Major
Multiples. At the same time, we will focus on improving efficiency
at the existing Blackburn sites to further increase our total
capacity."
For further information
please contact:
Zeus Capital Limited (Nominated
Adviser & Broker)
Dan Bate / Jonathan Sharp Tel: +44 (0) 161 831
1512
Dominic King / Adam Pollock Tel: +44 (0) 20 3829
/ Mike Seabrook 5000
Camarco (Media enquiries)
Jennifer Renwick / Billy Tel: +44 (0) 203 757
Clegg 4994
Notes to Editors
Accrol manufactures toilet rolls, kitchen rolls and facial
tissues as well as other tissue products at the Company's 350,000
sq. ft. manufacturing, storage and distribution facility in
Blackburn, Lancashire. Accrol currently manufactures approximately
16 million units per week and supplies some of the UK's largest
retailers, providing both Accrol branded and Private Label
products.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFVRAAILIIR
(END) Dow Jones Newswires
September 02, 2016 02:00 ET (06:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024